Latest

Sanofi pursues sale of painkiller after political controversy
Sanofi pursues sale of painkiller after political controversy
Economy
by  AFP

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy. The sale of a controlling 50-percent stake in Opella to CD&R values the maker of France's leading painkiller, Doliprane, at 16 billion euros ($17.4 billion), Sanofi said.